09 Nov 2021
Promising new data from the ACROBAT Advance ongoing open label extension trial of paltusotine for acromegaly patients was announced by Crinetics Pharmaceuticals, Inc at the annual Society for Endocrinology conference in Edinburgh this week.
Migraines and menopause symptoms linked to cardiovascular disease risk
19 Apr 2024
Risk of postpartum depression associated with stress during adolescence
19 Apr 2024
Surgery for hypoparathyroidism sees reduced facture rates
19 Apr 2024
Patients with type 2 diabetes taking antidepressants have a higher mortality risk
19 Apr 2024
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024